<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8"/>
  <meta name="viewport" content="width=device-width, initial-scale=1"/>
  <title>About — COVIDAccountabilityNow</title>
  <link rel="stylesheet" href="/assets/site.css"/>
</head>
<body>
  <nav class="top"><div class="inner">
    <a href="/index.html">Home</a>
    <a href="/complaint-portal.html">Portal</a>
    <a class="active" href="/about.html">About</a>
    <a href="/who-can-report.html">Who can report</a>
    <a href="/why-report.html">Why report</a>
    <a href="/our-story.html">Our story</a>
    <a href="/privacy.html">Privacy</a>
    <a href="/disclaimer.html">Disclaimer</a>
  </div></nav>

  <main class="container">
    <h1>About</h1>

    <!-- Top content (exact language you provided) -->
    <section class="card">
      <h2>ABOUT US</h2>
      <p>
        COVIDAccountabilityNow is a community which understands that the COVID modRNA gene treatment resulted in
        unprecedented harm to the US population as documented in the CDC VAERS and V-safe reporting systems as well as
        numerous other sources. <a target="_blank" rel="noopener" href="https://openvaers.com/">https://openvaers.com/</a>
      </p>
    </section>

    <section class="card">
      <h2>WHAT WE OFFER</h2>
      <p>Free assistance with filing your injury to the medical board and support for advancing accountability.</p>
      <h3>MISSION</h3>
      <p>
        COVIDAccountabilityNow is committed to assist those suffering adverse events with reporting their injury to the
        appropriate medical board for further investigation and accountability.
      </p>
    </section>

    <section class="card">
      <h2>GOALS</h2>
      <ol class="small">
        <li>Facilitate wider public attention to and transparency for problems associated with the gene based treatment.</li>
        <li>Expand funding for nonprofit organizations attempting to assist those in need.</li>
        <li>Decelerate the ongoing morbidity and mortality associated with this treatment.</li>
        <li>Foster physician reeducation involving basic interpretation of the medical literature and medical ethics for the general benefit of public health.</li>
        <li>
          Curtail misinformation spread by public health officials.
          <a target="_blank" rel="noopener" href="https://oversight.house.gov/release/final-report-covid-select-concludes-2-year-investigation-issues-500-page-final-report-on-lessons-learned-and-the-path-forward/">
            Congressional report
          </a>
        </li>
        <li>
          Prevent future “mass iatrogenic” events.
          <a target="_blank" rel="noopener" href="https://www.researchgate.net/publication/373989367_COVID-19_vaccine-associated_mortality_in_the_Southern_Hemisphere">
            Southern Hemisphere study
          </a>
        </li>
      </ol>
    </section>

    <section class="card">
      <h2>CORE VALUES</h2>
      <ol class="small">
        <li>Critical thinking and proper scientific methodology in vaccine clinical research.</li>
        <li>Physician competency at benefit-risk assessment regarding new medical treatments.</li>
        <li>Physician competency at communicating risks and benefits to patients.</li>
        <li>Ethical behavior in medicine, including respect for patient autonomy and informed consent or refusal.</li>
      </ol>
    </section>

    <!-- References (expanded by default; scrolls if long) -->
    <section class="card">
      <h2>Relevant reference material (including peer-reviewed literature)</h2>

      <div class="refs">
        <!-- Data & analyses -->
        <details open>
          <summary><strong>Data & analyses</strong></summary>
          <ul>
            <li><a target="_blank" rel="noopener" href="https://openvaers.com/">OpenVAERS</a></li>
            <li>Polack FP, et&nbsp;al. <em>Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.</em> N Engl J Med. 2020;383:2603-2615. <a target="_blank" rel="noopener" href="https://doi.org/10.1056/NEJMoa2034577">10.1056/NEJMoa2034577</a></li>
            <li>Brown RB. <em>Relative risk reduction: Misinformative measure in clinical trials and COVID-19 vaccine efficacy.</em> Dialogues Health. 2022;1:100074. <a target="_blank" rel="noopener" href="https://doi.org/10.1016/j.dialog.2022.100074">10.1016/j.dialog.2022.100074</a></li>
            <li>Stadel B, et&nbsp;al. <em>Misleading Use of Risk Ratios.</em> Lancet. 2005;365(9467):1306-1307. <a target="_blank" rel="noopener" href="https://doi.org/10.1016/S0140-6736(05)61024-0">https://doi.org/10.1016/S0140-6736(05)61024-0</a></li>
            <li>Fraiman J, et&nbsp;al. <em>Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults.</em> Vaccine. 2022;40(40):5798–5805. <a target="_blank" rel="noopener" href="https://doi.org/10.1016/j.vaccine.2022.08.036">10.1016/j.vaccine.2022.08.036</a></li>
            <li>Perlis RH, et&nbsp;al. <em>Trust in Physicians and Hospitals During the COVID-19 Pandemic…</em> JAMA Netw Open. 2024;7(7):e2424984. <a target="_blank" rel="noopener" href="https://doi.org/10.1001/jamanetworkopen.2024.24984">10.1001/jamanetworkopen.2024.24984</a></li>
            <li>Rancourt D, et&nbsp;al. <em>Spatiotemporal variation of excess all-cause mortality…</em> Correlation Research in the Public Interest, 2024. <a target="_blank" rel="noopener" href="https://correlation-canada.org/covid-excess-mortality-125-countries/">link</a></li>
            <li>Rancourt D, et&nbsp;al. <em>COVID-19 vaccine-associated mortality in the Southern Hemisphere.</em> ResearchGate. 2023. <a target="_blank" rel="noopener" href="https://doi.org/10.13140/RG.2.2.24720.79366">10.13140/RG.2.2.24720.79366</a></li>
            <li>Beattie K. <em>Worldwide Bayesian Causal Impact Analysis… 145 Countries.</em> ResearchGate. 2021. <a target="_blank" rel="noopener" href="https://doi.org/10.13140/RG.2.2.34214.65605">10.13140/RG.2.2.34214.65605</a></li>
          </ul>
        </details>

        <!-- Ethics & medical standards -->
        <details open>
          <summary><strong>Ethics & medical standards</strong></summary>
          <ul>
            <li>USMLE® Content Outline (Biostatistics, Epidemiology/Population Health &amp; Interpretation of the Medical Literature), 2024:37. <a target="_blank" rel="noopener" href="https://www.usmle.org/sites/default/files/2022-01/USMLE_Content_Outline_0.pdf">PDF</a></li>
            <li>USMLE® Content Outline (Social Sciences), 2024:39. <a target="_blank" rel="noopener" href="https://www.usmle.org/sites/default/files/2022-01/USMLE_Content_Outline_0.pdf">PDF</a></li>
            <li><em>First Aid for the USMLE Step 1</em> (Public Health Sciences: Epidemiology &amp; Biostatistics). McGraw-Hill, 2022:260. <a target="_blank" rel="noopener" href="https://archive.org/details/fa-2022/mode/2up">archive.org</a></li>
            <li><em>First Aid for the USMLE Step 1</em> (Public Health Sciences: Ethics). McGraw-Hill, 2022:268–269. <a target="_blank" rel="noopener" href="https://archive.org/details/fa-2022/mode/2up">archive.org</a></li>
            <li>ACP MKSAP — Interpreting &amp; Applying the Medical Literature (MK19). <a target="_blank" rel="noopener" href="https://www.acponline.org/featured-products/acp-mksap">link</a></li>
            <li>AAFP — Shared Decision-Making (NICE guidelines). <a target="_blank" rel="noopener" href="https://www.aafp.org/pubs/afp/issues/2022/0800/practice-guidelines-shared-decision-making.html">link</a></li>
            <li>FDA — <em>Communicating Risks and Benefits: An Evidence-Based User’s Guide</em> (Quantitative Information). <a target="_blank" rel="noopener" href="https://www.fda.gov/media/81597/download">PDF</a></li>
            <li>AHRQ — <em>SHARE Approach: Communicating Numbers to Your Patients</em>. <a target="_blank" rel="noopener" href="https://www.ahrq.gov/sites/default/files/wysiwyg/professionals/education/curriculum-tools/shareddecisionmaking/tools/tool-5/share-tool5.pdf">PDF</a></li>
            <li>ACP — Ethics Manual (7th ed.). <a target="_blank" rel="noopener" href="https://doi.org/10.7326/M18-2160">10.7326/M18-2160</a></li>
            <li>AMA Code of Medical Ethics — Opinion 2.1.1 Informed Consent. <a target="_blank" rel="noopener" href="https://code-medical-ethics.ama-assn.org/ethics-opinions/informed-consent">link</a></li>
            <li>AMA Code — Opinion 8.3 Physicians’ Responsibilities in Disaster Response &amp; Preparedness. <a target="_blank" rel="noopener" href="https://code-medical-ethics.ama-assn.org/ethics-opinions/physicians-responsibilities-disaster-response-preparedness">link</a></li>
          </ul>
        </details>

        <!-- Policy & governance -->
        <details open>
          <summary><strong>Policy & governance</strong></summary>
          <ul>
            <li>HHS ASPR — PREP Act Questions &amp; Answers. <a target="_blank" rel="noopener" href="https://aspr.hhs.gov/legal/PREPact/Pages/PREP-Act-Question-and-Answers.aspx">link</a></li>
            <li>Federal Register — Impact of Health Misinformation in the Digital Information Environment (RFI), 2022-03-07. <a target="_blank" rel="noopener" href="https://www.federalregister.gov/documents/2022/03/07/2022-04777/impact-of-health-misinformation-in-the-digital-information-environment-in-the-united-states">link</a></li>
            <li>FSMB — Professional Expectations Regarding Medical Misinformation &amp; Disinformation (Apr 2022). <a target="_blank" rel="noopener" href="https://www.fsmb.org/siteassets/advocacy/policies/ethics-committee-report-misinformation-april-2022-final.pdf">PDF</a></li>
            <li>AMA — Adopts policy addressing public health disinformation (Jun 13, 2022). <a target="_blank" rel="noopener" href="https://www.ama-assn.org/press-center/press-releases/ama-adopts-new-policy-aimed-addressing-public-health-disinformation">link</a></li>
            <li>White House — Fact Sheet (May 9, 2023). <a target="_blank" rel="noopener" href="https://www.whitehouse.gov/briefing-room/statements-releases/2023/05/09/fact-sheet-actions-taken-by-the-biden-harris-administration-to-ensure-continued-covid-19-protections-and-surge-preparedness-after-public-health-emergency-transition/">link</a></li>
            <li>House Oversight — Final Report on Lessons Learned and the Path Forward (Dec 2, 2024). <a target="_blank" rel="noopener" href="https://oversight.house.gov/release/final-report-covid-select-concludes-2-year-investigation-issues-500-page-final-report-on-lessons-learned-and-the-path-forward/">link</a></li>
          </ul>
        </details>

        <!-- Legal & court filings -->
        <details open>
          <summary><strong>Legal & court filings</strong></summary>
          <ul>
            <li>Texas AG — <em>State of Texas v. Pfizer Inc.</em> (2023). <a target="_blank" rel="noopener" href="https://www.texasattorneygeneral.gov/sites/default/files/images/press/Pfizer%20Vaccine%20Petition%20Filed.pdf">PDF</a></li>
            <li>Kansas AG — <em>State of Kansas v. Pfizer Inc.</em> (2024). <a target="_blank" rel="noopener" href="https://ag.ks.gov/docs/default-source/documents/2024-06-15-pfizer-complaint-(002).pdf?sfvrsn=eb8bbe1a_8">PDF</a></li>
            <li>U.S. Supreme Court — NFIB v. OSHA (595 U.S. 109, 2022). <a target="_blank" rel="noopener" href="https://www.supremecourt.gov/opinions/21pdf/21a244_hgci.pdf">PDF</a></li>
          </ul>
        </details>

        <!-- Media & commentary -->
        <details open>
          <summary><strong>Media & commentary</strong></summary>
          <ul>
            <li>Vella D. <em>Failure of Care Standard Involving Pfizer BNT162b2 modRNA.</em> G Med Sci. 2024;5(1):156-163. Podcast page: <a target="_blank" rel="noopener" href="https://www.thegms.co/podcasts/care-standard-failure/">link</a> · DOI: <a target="_blank" rel="noopener" href="https://www.doi.org/10.46766/thegms">10.46766/thegms</a></li>
          </ul>
        </details>
      </div>
    </section>
  </main>

  <footer><a href="/privacy.html">Privacy</a> · <a href="/disclaimer.html">Disclaimer</a></footer>
</body>
</html>

